Journals / Haseki Tıp Bülteni / 2022 / Cilt: 60 - Sayı: 3

Parkinson’s Disease and the COVID-19 Pandemic: Do Quarantine Affect the Motor and Non-Motor Symptoms of Patients with and without Deep Brain Stimulation?

Pages
204–210
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Telemedicine and online physiotherapy programs should be recommended to prevent rapid disease progression.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Patients with chronic diseases were forced into lockdown due to the coronavirus disease-2019 pandemic.
📊
Key Findings & Data:Methods: This study included 168 patients with PD who were in quarantine for 2 months (between April 1, 2020 and May 31, 2020).
💡
Conclusion & Impact:Telemedicine and online physiotherapy programs should be recommended to prevent rapid disease progression.
🔬Design:Survey & Empirical Study
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Patients with chronic diseases were forced into lockdown due to the coronavirus disease-2019 pandemic. Extended quarantine could lead to physical inactivity and psychiatric problems. We investigated the effects of quarantine and social isolation during the pandemic on the motor and non-motor symptoms (NMS) of Parkinson’s disease (PD) patients with and without deep brain stimulation (DBS). Methods: This study included 168 patients with PD who were in quarantine for 2 months (between April 1, 2020 and May 31, 2020). Eighty-three patients had undergone bilateral subthalamic DBS surgery. A questionnaire with three parts was administered via phone: 1) motor symptoms, 2) NMS, and 3) the reasons for impairment. Results: Of the patients, 54.7% reported impairment in at least one motor symptom and 58.9% reported impairment in at least one NMS. Increased tremors, difficulty with turning in bed, and insomnia were significantly more pronounced in patients without DBS. Patients with DBS complained less of being bored due to staying at home and had less deterioration due to lack of exercise and slower disease progression. Conclusion: Half of the symptoms of patients with PD worsened during quarantine, but patients with DBS tolerated the lockdown better. Telemedicine and online physiotherapy programs should be recommended to prevent rapid disease progression.

🔖

Cite This Article

KILIÇ, B. B., ZIRH, T. A., HANOĞLU, L., YILMAZ, N. H., ASLAN, A. S. (2022). Parkinson’s Disease and the COVID-19 Pandemic: Do Quarantine Affect the Motor and Non-Motor Symptoms of Patients with and without Deep Brain Stimulation?. Haseki Tıp Bülteni, Cilt: 60 - Sayı: 3, 204–210. https://ajindex.com/articles/534953

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Wang L, He W, Yu X, et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. J Infect 2020;80:639-45
  2. Espinel PT, Chau JY, van der Ploeg HP, Merom D. Older adults' time in sedentary, light and moderate intensity activities and correlates: application of Australian Time Use Survey. J Sci Med Sport 2015;18:161-6
  3. Röhr S, Müller F, Jung F, et al. Psychosoziale Folgen von Quarantänemaßnahmen bei schwerwiegenden Coronavirus- Ausbrüchen: ein Rapid Review [Psychosocial Impact of Quarantine Measures During Serious Coronavirus Outbreaks: A Rapid Review]. Psychiatr Prax 2020;47:179-89
  4. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79:368-76
  5. Sveinbjornsdottir S. The clinical symptoms of Parkinson's disease. J Neurochem 2016;139 Suppl 1:318-24
  6. Cheng EM, Swarztrauber K, Siderowf AD, et al. Association of specialist involvement and quality of care for Parkinson's disease. Mov Disord 2007;22:515-22
  7. Willis AW, Schootman M, Evanoff BA, Perlmutter JS, Racette BA. Neurologist care in Parkinson disease: a utilization, outcomes, and survival study. Neurology 2011;77:851-7
  8. Kulkarni AS, Balkrishnan R, Anderson RT, Edin HM, Kirsch J, Stacy MA. Medication adherence and associated outcomes in medicare health maintenance organization-enrolled older adults with Parkinson's disease. Mov Disord 2008;23:359-65
  9. Jankovic J, Poewe W. Therapies in Parkinson's disease. Curr Opin Neurol 2012;25:433-47
  10. Mak MKY, Wong-Yu ISK. Exercise for Parkinson's disease. Int Rev Neurobiol 2019;147:1-44
  11. Helmich RC, Bloem BR. The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities. J Parkinsons Dis 2020;10:351-4
  12. Prasad S, Holla VV, Neeraja K, et al. Parkinson's Disease and COVID-19: Perceptions and Implications in Patients and Caregivers. Mov Disord 2020;35:912-4
  13. Falla M, Dodich A, Papagno C, et al. Lockdown effects on Parkinson's disease during COVID-19 pandemic: a pilot study. Acta Neurol Belg 2021;121:1191-8
  14. Malek N. Deep Brain Stimulation in Parkinson's Disease. Neurol India 2019;67:968-78
  15. Miocinovic S, Ostrem JL, Okun MS, et al. Recommendations for Deep Brain Stimulation Device Management During a Pandemic. J Parkinsons Dis 2020;10:903-10
  16. Schirinzi T, Cerroni R, Di Lazzaro G, et al. Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy. Neur